Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Dow
Novartis
Merck
Chinese Patent Office
Federal Trade Commission
Express Scripts
Accenture
Harvard Business School
Colorcon

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085082

« Back to Dashboard

NDA 085082 describes DICYCLOMINE HYDROCHLORIDE, which is a drug marketed by Hikma Pharms, Lannett, Mylan, Pioneer Pharms, Sun Pharm Industries, Watson Labs, Luitpold Pharms Inc, Alpharma Us Pharms, Mikart, and West-ward Pharms Int, and is included in nineteen NDAs. It is available from forty-four suppliers. Additional details are available on the DICYCLOMINE HYDROCHLORIDE profile page.

The generic ingredient in DICYCLOMINE HYDROCHLORIDE is dicyclomine hydrochloride. There are four drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.
Summary for 085082
Tradename:DICYCLOMINE HYDROCHLORIDE
Applicant:Watson Labs
Ingredient:dicyclomine hydrochloride
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 085082
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for 085082
Suppliers and Packaging for NDA: 085082
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 085082 ANDA Actavis Pharma, Inc. 0591-0794 N 0591-0794-01
DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 085082 ANDA Actavis Pharma, Inc. 0591-0794 N 0591-0794-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Jun 19, 1986TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
Daiichi Sankyo
Fuji
Cerilliant
McKesson
Boehringer Ingelheim
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot